Brief: Pixium Vision Implants 5th PRIMA In Patients With Atrophic Dry-AMD

Pixium Vision SA

10/07/2018 06:08

July 10 (Reuters) - PIXIUM VISION SA  PIX.PA :
    * REG-PIXIUM VISION COMPLETES IMPLANTATION OF PRIMA IN FIVE
PATIENTS WITH ATROPHIC DRY-AMD AS EXPECTED FOR FEASIBILITY
CLINICAL TRIAL IN FRANCE
    * ALSO SUCCESSFULLY ACTIVATED IN FOURTH CONSECUTIVE PATIENT
IN
STUDY
    * PATIENT WITH FIFTH AND FINAL IMPLANT WILL HAVE HIS DEVICE
ACTIVATED IN COMING WEEKS AS PER PROTOCOL
    * PARTNERSHIP ADVANCES GENEVANT’S GOAL OF HAVING 5-10
PROGRAMS IN 
CLINIC BY 2020 ACROSS RNAI, MRNA, AND GENE EDITING MODALITIES
    * STUDY CANDIDATES CONTINUE TO BE SCREENED AND FIRST
IMPLANTATIONS
ARE EXPECTED DURING Q3 2018

Source text for Eikon:  ID:nGNE89bnqx 
Further company coverage:  PIX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))